Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RUEL

Showing results (1341-1350 of 1,486) with videos related to

Pageof 149
Sort By:
The American Journal of Cardiology|February 4, 2017
Comparison of Outcomes of Balloon-Expandable Versus Self-Expandable Transcatheter Heart Valves for Severe Aortic StenosisHarindra C Wijeysundera, Feng Qiu, Maria Koh, et al.
Molecular Genetics and Metabolism|May 16, 2018
CCDC115-CDG: A new rare and misleading inherited cause of liver diseaseMuriel Girard, Aurélia Poujois, Monique Fabre, et al.
BMJ (Clinical Research Ed.)|October 12, 2019
Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysisKarla Solo, Shahar Lavi, Conrad Kabali, et al.
AIDS (London, England)|November 27, 2018
Eliminating perinatal HIV in the United States: mission possible?Devasena Gnanashanmugam, Natella Rakhmanina, Keith W Crawford, et al.
Cancer Immunology, Immunotherapy : CII|June 9, 2023
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancerColt A Egelston, Weihua Guo, Susan E Yost, et al.
Biomaterials|March 18, 2014
The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardiumAli Ahmadi, Brian McNeill, Branka Vulesevic, et al.
Gynecologic Oncology|January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancerMihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia in Canada: An Observational StudyLeslie Brown, Isabelle Ruel, Alexis Baass, et al.
Cancer|October 11, 2018
NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanomaAhmad A Tarhini, Paul Frankel, Christopher Ruel, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|January 2, 2018
Gaps in the Child Tuberculosis Care Cascade in 32 Rural Communities in Uganda and KenyaFlorence Mwangwa, Gabriel Chamie, Dalsone Kwarisiima, et al.
Pageof 149

Showing results (1341-1350 of 1,486) with videos related to

Sort By:
Pageof 149
The American Journal of Cardiology|February 4, 2017
Comparison of Outcomes of Balloon-Expandable Versus Self-Expandable Transcatheter Heart Valves for Severe Aortic StenosisHarindra C Wijeysundera, Feng Qiu, Maria Koh, et al.
Molecular Genetics and Metabolism|May 16, 2018
CCDC115-CDG: A new rare and misleading inherited cause of liver diseaseMuriel Girard, Aurélia Poujois, Monique Fabre, et al.
BMJ (Clinical Research Ed.)|October 12, 2019
Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysisKarla Solo, Shahar Lavi, Conrad Kabali, et al.
AIDS (London, England)|November 27, 2018
Eliminating perinatal HIV in the United States: mission possible?Devasena Gnanashanmugam, Natella Rakhmanina, Keith W Crawford, et al.
Cancer Immunology, Immunotherapy : CII|June 9, 2023
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancerColt A Egelston, Weihua Guo, Susan E Yost, et al.
Biomaterials|March 18, 2014
The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardiumAli Ahmadi, Brian McNeill, Branka Vulesevic, et al.
Gynecologic Oncology|January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancerMihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia in Canada: An Observational StudyLeslie Brown, Isabelle Ruel, Alexis Baass, et al.
Cancer|October 11, 2018
NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanomaAhmad A Tarhini, Paul Frankel, Christopher Ruel, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|January 2, 2018
Gaps in the Child Tuberculosis Care Cascade in 32 Rural Communities in Uganda and KenyaFlorence Mwangwa, Gabriel Chamie, Dalsone Kwarisiima, et al.
Pageof 149